ROCK SPRINGS CAPITAL MANAGEMENT LP Holdings

ROCK SPRINGS CAPITAL MANAGEMENT LP is an investment fund managing more than 3.87B US dollars. The largest holdings include Humana, agilon health and Immunocore Holdings. In Q3 2022 the fund bought assets of total value of 494.14M US dollars and sold assets of total value of 11.41M US dollars.

$3.87B

portfolio value

+8.56%

quarter

-32.99%

1 year

-25.85%

3 years

-26.98%

5 years

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	-51958000	30267000
Q2 2016	195734000	30242000
Q3 2016	310772000	45999000
Q4 2016	95116000	117328000
Q1 2017	188044000	33340000
Q2 2017	386124000	162563000
Q3 2017	249161000	47394000
Q4 2017	225180000	128676000
Q1 2018	409982000	225165000
Q2 2018	370617000	127612000
Q3 2018	307594000	212290000
Q4 2018	-95344000	415123000
Q1 2019	414256000	64289000
Q2 2019	247389000	86458000
Q3 2019	126356000	260075000
Q4 2019	674924000	197229000
Q1 2020	159313000	477666000
Q2 2020	1080176000	32564000
Q3 2020	405449000	162995000
Q4 2020	1002170000	201385000
Q1 2021	685519000	759679000
Q2 2021	652068000	174000000
Q3 2021	191354000	423554000
Q4 2021	-66782000	366633000
Q1 2022	-159757000	152883000
Q2 2022	-177488000	271859000
Q3 2022	494135000	11409000

ROCK SPRINGS CAPITAL MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Healthcare Plans Humana Inc. Portfolio share: 5.34% Portfolio value: 206.93M Avg. open price: $406.62 Current price: $547.42 P/L: +34.63% Bought +0.03% shares Q3 2022	share	5.34%	206.93M	$406.62	$547.42	+34.63%	Bought +0.03% shares Q3 2022
Medical Care Facilities agilon health, inc. Portfolio share: 4.69% Portfolio value: 181.44M Avg. open price: $27.44 Current price: $17.7 P/L: -35.51% Bought +0.87% shares Q3 2022	share	4.69%	181.44M	$27.44	$17.7	-35.51%	Bought +0.87% shares Q3 2022
Biotechnology Immunocore Holdings plc Portfolio share: 4.24% Portfolio value: 163.99M Avg. open price: $36.87 Current price: $58.07 P/L: +57.48% Bought +30.77% shares Q3 2022	share	4.24%	163.99M	$36.87	$58.07	+57.48%	Bought +30.77% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 3.52% Portfolio value: 136.10M Avg. open price: $206.88 Current price: $535.04 P/L: +158.63% Bought +0.37% shares Q3 2022	share	3.52%	136.10M	$206.88	$535.04	+158.63%	Bought +0.37% shares Q3 2022
Biotechnology argenx SE Portfolio share: 3.19% Portfolio value: 123.56M Avg. open price: $168.48 Current price: $393.21 P/L: +133.39% Bought +11.11% shares Q1 2022	share	3.19%	123.56M	$168.48	$393.21	+133.39%	Bought +11.11% shares Q1 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 3.08% Portfolio value: 119.22M Avg. open price: $91.91 Current price: $124 P/L: +34.92% Bought +1.58% shares Q2 2022	share	3.08%	119.22M	$91.91	$124	+34.92%	Bought +1.58% shares Q2 2022
Medical Devices Insulet Corporation Portfolio share: 3.07% Portfolio value: 118.94M Avg. open price: $237.31 Current price: $302.43 P/L: +27.44% Bought +3.29% shares Q3 2022	share	3.07%	118.94M	$237.31	$302.43	+27.44%	Bought +3.29% shares Q3 2022
Health Information Services Evolent Health, Inc. Portfolio share: 3.03% Portfolio value: 117.22M Avg. open price: $28.08 Current price: $28.66 P/L: +2.07% Bought +19.16% shares Q3 2022	share	3.03%	117.22M	$28.08	$28.66	+2.07%	Bought +19.16% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 2.62% Portfolio value: 101.35M Avg. open price: $68.4 Current price: $50.19 P/L: -26.62% Bought +57.09% shares Q3 2022	share	2.62%	101.35M	$68.4	$50.19	-26.62%	Bought +57.09% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 2.40% Portfolio value: 93.06M Avg. open price: $106.3 Current price: $226.95 P/L: +113.50% Sold -6.37% shares Q3 2022	share	2.40%	93.06M	$106.3	$226.95	+113.50%	Sold -6.37% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 2.33% Portfolio value: 90.25M Avg. open price: $173.78 Current price: $212 P/L: +21.99% Bought +18.56% shares Q3 2022	share	2.33%	90.25M	$173.78	$212	+21.99%	Bought +18.56% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 2.23% Portfolio value: 86.47M Avg. open price: $40.03 Current price: $29.8 P/L: -25.56% Bought +4.42% shares Q3 2022	share	2.23%	86.47M	$40.03	$29.8	-25.56%	Bought +4.42% shares Q3 2022
Diagnostics & Research IDEXX Laboratories, Inc. Portfolio share: 1.89% Portfolio value: 73.08M Avg. open price: $434.43 Current price: $422.3 P/L: -2.79% Bought +0.25% shares Q3 2022	share	1.89%	73.08M	$434.43	$422.3	-2.79%	Bought +0.25% shares Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 1.84% Portfolio value: 71.24M Avg. open price: $388.7 Current price: $187.96 P/L: -51.64% Sold -2.96% shares Q3 2022	share	1.84%	71.24M	$388.7	$187.96	-51.64%	Sold -2.96% shares Q3 2022
Biotechnology Cerevel Therapeutics Holdings, Inc. Portfolio share: 1.82% Portfolio value: 70.62M Avg. open price: $26.65 Current price: $28.31 P/L: +6.22% Bought +41.42% shares Q3 2022	share	1.82%	70.62M	$26.65	$28.31	+6.22%	Bought +41.42% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 1.72% Portfolio value: 66.55M Avg. open price: $105.96 Current price: $226.4 P/L: +113.67% Bought +6.91% shares Q4 2021	share	1.72%	66.55M	$105.96	$226.4	+113.67%	Bought +6.91% shares Q4 2021
Medical Care Facilities Acadia Healthcare Company, Inc. Portfolio share: 1.71% Portfolio value: 66.06M Avg. open price: $44.19 Current price: $85.65 P/L: +93.80% Bought +12.14% shares Q3 2022	share	1.71%	66.06M	$44.19	$85.65	+93.80%	Bought +12.14% shares Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 1.61% Portfolio value: 62.35M Avg. open price: $8.4 Current price: $15.66 P/L: +86.44% Bought +0.87% shares Q3 2022	share	1.61%	62.35M	$8.4	$15.66	+86.44%	Bought +0.87% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 1.56% Portfolio value: 60.53M Avg. open price: $103.82 Current price: $92.75 P/L: -10.67% Bought +2.58% shares Q3 2022	share	1.56%	60.53M	$103.82	$92.75	-10.67%	Bought +2.58% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 1.45% Portfolio value: 55.95M Avg. open price: $106.81 Current price: $269.72 P/L: +152.53% Sold -17.08% shares Q1 2022	share	1.45%	55.95M	$106.81	$269.72	+152.53%	Sold -17.08% shares Q1 2022
Drug Manufacturers—Specialty & Generic Pacira BioSciences, Inc. Portfolio share: 1.40% Portfolio value: 54.12M Avg. open price: $41.57 Current price: $46.75 P/L: +12.45% Bought +1.75% shares Q2 2022	share	1.40%	54.12M	$41.57	$46.75	+12.45%	Bought +1.75% shares Q2 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 1.35% Portfolio value: 52.14M Avg. open price: $45.57 Current price: $73.85 P/L: +62.05% Bought +4.82% shares Q3 2022	share	1.35%	52.14M	$45.57	$73.85	+62.05%	Bought +4.82% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 1.29% Portfolio value: 50.08M Avg. open price: $140.32 Current price: $243.11 P/L: +73.25% Sold -25.11% shares Q3 2022	share	1.29%	50.08M	$140.32	$243.11	+73.25%	Sold -25.11% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 1.27% Portfolio value: 49.19M Avg. open price: $73.58 Current price: $39.83 P/L: -45.87% Bought +8.69% shares Q3 2022	share	1.27%	49.19M	$73.58	$39.83	-45.87%	Bought +8.69% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 1.23% Portfolio value: 47.53M Avg. open price: $70.63 Current price: $122.96 P/L: +74.09% Bought +0.47% shares Q3 2022	share	1.23%	47.53M	$70.63	$122.96	+74.09%	Bought +0.47% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 1.20% Portfolio value: 46.64M Avg. open price: $15.43 Current price: $44.04 P/L: +185.43% Bought +101.61% shares Q3 2022	share	1.20%	46.64M	$15.43	$44.04	+185.43%	Bought +101.61% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.16% Portfolio value: 44.99M Avg. open price: $99.42 Current price: $98.48 P/L: -0.95% Sold -2.55% shares Q3 2022	share	1.16%	44.99M	$99.42	$98.48	-0.95%	Sold -2.55% shares Q3 2022
Medical Instruments & Supplies West Pharmaceutical Services, Inc. Portfolio share: 1.15% Portfolio value: 44.41M Avg. open price: $332.59 Current price: $239.44 P/L: -28.01% Bought +62.61% shares Q3 2022	share	1.15%	44.41M	$332.59	$239.44	-28.01%	Bought +62.61% shares Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 1.13% Portfolio value: 43.93M Avg. open price: $108.64 Current price: $119.41 P/L: +9.92% Bought +1.92% shares Q2 2022	share	1.13%	43.93M	$108.64	$119.41	+9.92%	Bought +1.92% shares Q2 2022
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 1.11% Portfolio value: 43.14M Avg. open price: $13.64 Current price: $27.14 P/L: +98.93% Bought +25.48% shares Q3 2022	share	1.11%	43.14M	$13.64	$27.14	+98.93%	Bought +25.48% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 1.08% Portfolio value: 41.73M Avg. open price: $24.35 Current price: $38.83 P/L: +59.47% Bought +2.88% shares Q3 2022	share	1.08%	41.73M	$24.35	$38.83	+59.47%	Bought +2.88% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 1.06% Portfolio value: 41.13M Avg. open price: $19.48 Current price: $60.39 P/L: +210.03% Bought +2.25% shares Q2 2022	share	1.06%	41.13M	$19.48	$60.39	+210.03%	Bought +2.25% shares Q2 2022
Biotechnology Zai Lab Limited Portfolio share: 1.05% Portfolio value: 40.78M Avg. open price: $72.55 Current price: $33.74 P/L: -53.49% Sold -1.93% shares Q3 2022	share	1.05%	40.78M	$72.55	$33.74	-53.49%	Sold -1.93% shares Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 1.05% Portfolio value: 40.69M Avg. open price: $78.58 Current price: $51.3 P/L: -34.71% Bought +7.68% shares Q3 2022	share	1.05%	40.69M	$78.58	$51.3	-34.71%	Bought +7.68% shares Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 1.02% Portfolio value: 39.57M Avg. open price: $18.84 Current price: $12.33 P/L: -34.55% Bought +18.09% shares Q3 2022	share	1.02%	39.57M	$18.84	$12.33	-34.55%	Bought +18.09% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 1.02% Portfolio value: 39.50M Avg. open price: $446.13 Current price: $116.56 P/L: -73.87% Bought +3.74% shares Q3 2022	share	1.02%	39.50M	$446.13	$116.56	-73.87%	Bought +3.74% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 0.98% Portfolio value: 38.08M Avg. open price: $27.5 Current price: $37.72 P/L: +37.15% Bought +0.14% shares Q3 2022	share	0.98%	38.08M	$27.5	$37.72	+37.15%	Bought +0.14% shares Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.97% Portfolio value: 37.72M Avg. open price: $14.42 Current price: $18.33 P/L: +27.10% Bought +4.54% shares Q3 2022	share	0.97%	37.72M	$14.42	$18.33	+27.10%	Bought +4.54% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.96% Portfolio value: 37.21M Avg. open price: $84.33 Current price: $121.22 P/L: +43.75% Bought +0.55% shares Q2 2022	share	0.96%	37.21M	$84.33	$121.22	+43.75%	Bought +0.55% shares Q2 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 0.95% Portfolio value: 36.73M Avg. open price: $75.12 Current price: $102.75 P/L: +36.78% Bought +8.61% shares Q3 2022	share	0.95%	36.73M	$75.12	$102.75	+36.78%	Bought +8.61% shares Q3 2022
Medical Devices Nevro Corp. Portfolio share: 0.95% Portfolio value: 36.67M Avg. open price: $110.05 Current price: $43.47 P/L: -60.50% Bought +1.77% shares Q3 2022	share	0.95%	36.67M	$110.05	$43.47	-60.50%	Bought +1.77% shares Q3 2022
Packaged Foods Freshpet, Inc. Portfolio share: 0.91% Portfolio value: 35.06M Avg. open price: $76.36 Current price: $60.82 P/L: -20.35% Bought +9.79% shares Q3 2022	share	0.91%	35.06M	$76.36	$60.82	-20.35%	Bought +9.79% shares Q3 2022
Medical Distribution Covetrus, Inc. Portfolio share: 0.91% Portfolio value: 35.05M Avg. open price: $15.42 Current price: $20.99 P/L: +36.11% Bought +0.23% shares Q2 2022	share	0.91%	35.05M	$15.42	$20.99	+36.11%	Bought +0.23% shares Q2 2022
Health Information Services Phreesia, Inc. Portfolio share: 0.86% Portfolio value: 33.18M Avg. open price: $31.4 Current price: $28.04 P/L: -10.69% Bought +0.33% shares Q3 2022	share	0.86%	33.18M	$31.4	$28.04	-10.69%	Bought +0.33% shares Q3 2022
Biotechnology Abcam plc Portfolio share: 0.79% Portfolio value: 30.46M Avg. open price: $18.41 Current price: $16.13 P/L: -12.39% Bought +25.42% shares Q3 2022	share	0.79%	30.46M	$18.41	$16.13	-12.39%	Bought +25.42% shares Q3 2022
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 0.71% Portfolio value: 27.55M Avg. open price: $11.72 Current price: $7.05 P/L: -39.84% Bought +8.52% shares Q2 2022	share	0.71%	27.55M	$11.72	$7.05	-39.84%	Bought +8.52% shares Q2 2022
Health Information Services Accolade, Inc. Portfolio share: 0.67% Portfolio value: 25.96M Avg. open price: $31.02 Current price: $8.34 P/L: -73.12% Bought +3.36% shares Q3 2022	share	0.67%	25.96M	$31.02	$8.34	-73.12%	Bought +3.36% shares Q3 2022
Health Care Select Sector SPDR Fund Portfolio share: 0.63% Portfolio value: 24.22M Avg. open price: N/A Current price: $138.43 P/L: N/A N/A Q2 2022	share	0.63%	24.22M	N/A	$138.43	N/A	N/A Q2 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 0.61% Portfolio value: 23.44M Avg. open price: $27.1 Current price: $20.01 P/L: -26.15% Sold -36.42% shares Q4 2021	share	0.61%	23.44M	$27.1	$20.01	-26.15%	Sold -36.42% shares Q4 2021
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 0.59% Portfolio value: 22.78M Avg. open price: $30.45 Current price: $29.11 P/L: -4.39% Bought +34.91% shares Q3 2022	share	0.59%	22.78M	$30.45	$29.11	-4.39%	Bought +34.91% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.58% Portfolio value: 22.42M Avg. open price: $76.14 Current price: $103.53 P/L: +35.97% Bought +0.19% shares Q1 2022	share	0.58%	22.42M	$76.14	$103.53	+35.97%	Bought +0.19% shares Q1 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.56% Portfolio value: 21.57M Avg. open price: $6.54 Current price: $11.58 P/L: +77.14% Bought +17.21% shares Q3 2022	share	0.56%	21.57M	$6.54	$11.58	+77.14%	Bought +17.21% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.55% Portfolio value: 21.46M Avg. open price: $27.5 Current price: $38.12 P/L: +38.63% Bought +10.75% shares Q3 2022	share	0.55%	21.46M	$27.5	$38.12	+38.63%	Bought +10.75% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 0.53% Portfolio value: 20.63M Avg. open price: $33.18 Current price: $72.87 P/L: +119.64% Bought +16.08% shares Q2 2022	share	0.53%	20.63M	$33.18	$72.87	+119.64%	Bought +16.08% shares Q2 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.50% Portfolio value: 19.19M Avg. open price: $15.28 Current price: $21.42 P/L: +40.18% Bought +10.87% shares Q3 2022	share	0.50%	19.19M	$15.28	$21.42	+40.18%	Bought +10.87% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.49% Portfolio value: 19.01M Avg. open price: N/A Current price: $9.29 P/L: N/A N/A Q3 2022	share	0.49%	19.01M	N/A	$9.29	N/A	N/A Q3 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.49% Portfolio value: 18.79M Avg. open price: $78.84 Current price: $45.55 P/L: -42.22% Bought +1.03% shares Q3 2022	share	0.49%	18.79M	$78.84	$45.55	-42.22%	Bought +1.03% shares Q3 2022
Medical Devices CONMED Corporation Portfolio share: 0.48% Portfolio value: 18.68M Avg. open price: $129.71 Current price: $89.03 P/L: -31.36% Bought +4.48% shares Q3 2022	share	0.48%	18.68M	$129.71	$89.03	-31.36%	Bought +4.48% shares Q3 2022
Biotechnology Aura Biosciences, Inc. Portfolio share: 0.48% Portfolio value: 18.40M Avg. open price: $14.89 Current price: $12.38 P/L: -16.84% Bought +0.69% shares Q3 2022	share	0.48%	18.40M	$14.89	$12.38	-16.84%	Bought +0.69% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.47% Portfolio value: 18.37M Avg. open price: $46.63 Current price: $50.99 P/L: +9.34% Bought +26.69% shares Q3 2022	share	0.47%	18.37M	$46.63	$50.99	+9.34%	Bought +26.69% shares Q3 2022
Drug Manufacturers—Specialty & Generic Dynavax Technologies Corporation Portfolio share: 0.45% Portfolio value: 17.57M Avg. open price: $7.28 Current price: $12.3 P/L: +68.97% Bought +0.11% shares Q3 2022	share	0.45%	17.57M	$7.28	$12.3	+68.97%	Bought +0.11% shares Q3 2022
Diagnostics & Research Olink Holding AB (publ) Portfolio share: 0.45% Portfolio value: 17.54M Avg. open price: $19.42 Current price: $22 P/L: +13.31% Bought +17.31% shares Q3 2022	share	0.45%	17.54M	$19.42	$22	+13.31%	Bought +17.31% shares Q3 2022
Medical Instruments & Supplies Warby Parker Inc. Portfolio share: 0.45% Portfolio value: 17.46M Avg. open price: $41.34 Current price: $17.12 P/L: -58.59% Bought +2.82% shares Q3 2022	share	0.45%	17.46M	$41.34	$17.12	-58.59%	Bought +2.82% shares Q3 2022
Biotechnology Immatics N.V. Portfolio share: 0.43% Portfolio value: 16.81M Avg. open price: $8.71 Current price: $11.13 P/L: +27.78% Bought +49.05% shares Q3 2022	share	0.43%	16.81M	$8.71	$11.13	+27.78%	Bought +49.05% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.38% Portfolio value: 14.70M Avg. open price: $32.16 Current price: $28.65 P/L: -10.92% Bought +0.75% shares Q3 2022	share	0.38%	14.70M	$32.16	$28.65	-10.92%	Bought +0.75% shares Q3 2022
Medical Instruments & Supplies Azenta, Inc. Portfolio share: 0.37% Portfolio value: 14.15M Avg. open price: $72.1 Current price: $60.16 P/L: -16.56% Bought +103.83% shares Q3 2022	share	0.37%	14.15M	$72.1	$60.16	-16.56%	Bought +103.83% shares Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 0.36% Portfolio value: 13.83M Avg. open price: $33.37 Current price: $18.36 P/L: -44.98% Bought +2.76% shares Q2 2022	share	0.36%	13.83M	$33.37	$18.36	-44.98%	Bought +2.76% shares Q2 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.34% Portfolio value: 13.29M Avg. open price: $52.86 Current price: $78 P/L: +47.55% Bought +1.45% shares Q1 2020	share	0.34%	13.29M	$52.86	$78	+47.55%	Bought +1.45% shares Q1 2020
Medical Care Facilities LifeStance Health Group, Inc. Portfolio share: 0.34% Portfolio value: 13.24M Avg. open price: $19.51 Current price: $5.67 P/L: -70.94% Bought +18.52% shares Q4 2021	share	0.34%	13.24M	$19.51	$5.67	-70.94%	Bought +18.52% shares Q4 2021
Biotechnology Arvinas, Inc. Portfolio share: 0.32% Portfolio value: 12.46M Avg. open price: $30.09 Current price: $39.53 P/L: +31.39% Sold -38.79% shares Q2 2022	share	0.32%	12.46M	$30.09	$39.53	+31.39%	Sold -38.79% shares Q2 2022
Biotechnology Compass Therapeutics, Inc. Portfolio share: 0.31% Portfolio value: 12.16M Avg. open price: $2.65 Current price: $4.53 P/L: +70.94% Bought +0.10% shares Q3 2022	share	0.31%	12.16M	$2.65	$4.53	+70.94%	Bought +0.10% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.31% Portfolio value: 11.85M Avg. open price: $32.17 Current price: $36.66 P/L: +13.94% Bought +25.67% shares Q3 2022	share	0.31%	11.85M	$32.17	$36.66	+13.94%	Bought +25.67% shares Q3 2022
Drug Manufacturers—Specialty & Generic Collegium Pharmaceutical, Inc. Portfolio share: 0.30% Portfolio value: 11.61M Avg. open price: $15.51 Current price: $22.73 P/L: +46.52% Sold -19.44% shares Q4 2021	share	0.30%	11.61M	$15.51	$22.73	+46.52%	Sold -19.44% shares Q4 2021
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.29% Portfolio value: 11.36M Avg. open price: N/A Current price: $38.55 P/L: N/A Sold -58.55% shares Q3 2022	share	0.29%	11.36M	N/A	$38.55	N/A	Sold -58.55% shares Q3 2022
Biotechnology Novavax, Inc. Portfolio share: 0.28% Portfolio value: 10.90M Avg. open price: $54.72 Current price: $17.61 P/L: -67.82% Bought +26.14% shares Q3 2022	share	0.28%	10.90M	$54.72	$17.61	-67.82%	Bought +26.14% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.28% Portfolio value: 10.76M Avg. open price: $94.24 Current price: $51.95 P/L: -44.87% Bought +5.26% shares Q4 2020	share	0.28%	10.76M	$94.24	$51.95	-44.87%	Bought +5.26% shares Q4 2020
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 0.27% Portfolio value: 10.57M Avg. open price: $10.22 Current price: $12.37 P/L: +21.03% Sold -1.60% shares Q1 2021	share	0.27%	10.57M	$10.22	$12.37	+21.03%	Sold -1.60% shares Q1 2021
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 9.97M Avg. open price: $13.67 Current price: $22.77 P/L: +66.56% Sold -27.53% shares Q2 2022	share	0.26%	9.97M	$13.67	$22.77	+66.56%	Sold -27.53% shares Q2 2022
Medical Devices Pulmonx Corporation Portfolio share: 0.26% Portfolio value: 9.95M Avg. open price: $55.37 Current price: $6.18 P/L: -88.84% Sold -14.95% shares Q3 2022	share	0.26%	9.95M	$55.37	$6.18	-88.84%	Sold -14.95% shares Q3 2022
GOSSAMER BIO INC Portfolio share: 0.26% Portfolio value: 9.88M Avg. open price: N/A Current price: N/A P/L: N/A Sold -37.73% shares Q1 2022	share	0.26%	9.88M	N/A	N/A	N/A	Sold -37.73% shares Q1 2022
Shell Companies Orion Acquisition Corp. Portfolio share: 0.25% Portfolio value: 9.87M Avg. open price: N/A Current price: $10.08 P/L: N/A N/A Q1 2021	share	0.25%	9.87M	N/A	$10.08	N/A	N/A Q1 2021
Drug Manufacturers—Specialty & Generic Amryt Pharma plc Portfolio share: 0.24% Portfolio value: 9.17M Avg. open price: $9.04 Current price: $7.16 P/L: -20.79% Bought +0.99% shares Q3 2022	share	0.24%	9.17M	$9.04	$7.16	-20.79%	Bought +0.99% shares Q3 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.23% Portfolio value: 8.92M Avg. open price: $12.33 Current price: $7.05 P/L: -42.83% Bought +20.79% shares Q3 2022	share	0.23%	8.92M	$12.33	$7.05	-42.83%	Bought +20.79% shares Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 0.22% Portfolio value: 8.53M Avg. open price: $34.66 Current price: $10.84 P/L: -68.72% Sold -6.92% shares Q3 2022	share	0.22%	8.53M	$34.66	$10.84	-68.72%	Sold -6.92% shares Q3 2022
Diagnostics & Research Invitae Corporation Portfolio share: 0.22% Portfolio value: 8.33M Avg. open price: $22.48 Current price: $2.73 P/L: -87.86% Sold -3.09% shares Q3 2022	share	0.22%	8.33M	$22.48	$2.73	-87.86%	Sold -3.09% shares Q3 2022
Biotechnology Nkarta, Inc. Portfolio share: 0.21% Portfolio value: 8.11M Avg. open price: $13.93 Current price: $8.15 P/L: -41.49% Bought +20.85% shares Q2 2022	share	0.21%	8.11M	$13.93	$8.15	-41.49%	Bought +20.85% shares Q2 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 0.21% Portfolio value: 8.01M Avg. open price: $16.71 Current price: $4.91 P/L: -70.62% Bought +30.83% shares Q3 2022	share	0.21%	8.01M	$16.71	$4.91	-70.62%	Bought +30.83% shares Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 7.69M Avg. open price: $17.09 Current price: $13.67 P/L: -20.00% Bought +33.22% shares Q2 2022	share	0.20%	7.69M	$17.09	$13.67	-20.00%	Bought +33.22% shares Q2 2022
Biotechnology Inozyme Pharma, Inc. Portfolio share: 0.19% Portfolio value: 7.52M Avg. open price: $4.85 Current price: $1.36 P/L: -71.95% Bought +6.35% shares Q3 2022	share	0.19%	7.52M	$4.85	$1.36	-71.95%	Bought +6.35% shares Q3 2022
Medical Devices EDAP TMS S.A. Portfolio share: 0.19% Portfolio value: 7.50M Avg. open price: $6.48 Current price: $11.01 P/L: +69.98% Bought +10.98% shares Q2 2022	share	0.19%	7.50M	$6.48	$11.01	+69.98%	Bought +10.98% shares Q2 2022
Biotechnology Biomea Fusion, Inc. Portfolio share: 0.18% Portfolio value: 7.14M Avg. open price: N/A Current price: $6.77 P/L: N/A Sold -32.69% shares Q3 2022	share	0.18%	7.14M	N/A	$6.77	N/A	Sold -32.69% shares Q3 2022
Biotechnology Gamida Cell Ltd. Portfolio share: 0.17% Portfolio value: 6.55M Avg. open price: $2.34 Current price: $1.43 P/L: -38.99% Bought +89.42% shares Q3 2022	share	0.17%	6.55M	$2.34	$1.43	-38.99%	Bought +89.42% shares Q3 2022
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.14% Portfolio value: 5.37M Avg. open price: $2.22 Current price: $0.83 P/L: -62.46% Bought +0.23% shares Q3 2022	share	0.14%	5.37M	$2.22	$0.83	-62.46%	Bought +0.23% shares Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.14% Portfolio value: 5.30M Avg. open price: N/A Current price: $44.37 P/L: N/A N/A Q2 2022	share	0.14%	5.30M	N/A	$44.37	N/A	N/A Q2 2022
Biotechnology EQRx, Inc. Portfolio share: 0.13% Portfolio value: 4.95M Avg. open price: N/A Current price: $3.46 P/L: N/A N/A Q1 2022	share	0.13%	4.95M	N/A	$3.46	N/A	N/A Q1 2022
Biotechnology Paratek Pharmaceuticals, Inc. Portfolio share: 0.12% Portfolio value: 4.45M Avg. open price: $7.71 Current price: $2.04 P/L: -73.54% Bought +0.43% shares Q2 2022	share	0.12%	4.45M	$7.71	$2.04	-73.54%	Bought +0.43% shares Q2 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.11% Portfolio value: 4.29M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q1 2022	share	0.11%	4.29M	N/A	$12	N/A	N/A Q1 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.11% Portfolio value: 4.17M Avg. open price: $17.18 Current price: $6.38 P/L: -62.86% Bought +26.39% shares Q3 2022	share	0.11%	4.17M	$17.18	$6.38	-62.86%	Bought +26.39% shares Q3 2022
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.10% Portfolio value: 3.96M Avg. open price: $7.07 Current price: $2.43 P/L: -65.63% Bought +14.42% shares Q2 2022	share	0.10%	3.96M	$7.07	$2.43	-65.63%	Bought +14.42% shares Q2 2022
Biotechnology F-star Therapeutics, Inc. Portfolio share: 0.10% Portfolio value: 3.85M Avg. open price: N/A Current price: $5.55 P/L: N/A Sold -28.68% shares Q4 2021	share	0.10%	3.85M	N/A	$5.55	N/A	Sold -28.68% shares Q4 2021
Biotechnology Reneo Pharmaceuticals, Inc. Portfolio share: 0.10% Portfolio value: 3.83M Avg. open price: $9.33 Current price: $2.02 P/L: -78.35% Bought +1.25% shares Q3 2021	share	0.10%	3.83M	$9.33	$2.02	-78.35%	Bought +1.25% shares Q3 2021
TRAVERE THERAPEUTICS INC Portfolio share: 0.09% Portfolio value: 3.28M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2020	share	0.09%	3.28M	N/A	N/A	N/A	N/A Q1 2020
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.08% Portfolio value: 3.22M Avg. open price: $2.63 Current price: $0.52 P/L: -80.29% Bought +0.19% shares Q3 2022	share	0.08%	3.22M	$2.63	$0.52	-80.29%	Bought +0.19% shares Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.08% Portfolio value: 3.11M Avg. open price: $28.21 Current price: $6.56 P/L: -76.75% Sold -11.51% shares Q2 2022	share	0.08%	3.11M	$28.21	$6.56	-76.75%	Sold -11.51% shares Q2 2022
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.08% Portfolio value: 3.09M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.08%	3.09M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology Altimmune, Inc. Portfolio share: 0.07% Portfolio value: 2.85M Avg. open price: N/A Current price: $11.09 P/L: N/A N/A Q3 2022	share	0.07%	2.85M	N/A	$11.09	N/A	N/A Q3 2022
Biotechnology Adaptimmune Therapeutics plc Portfolio share: 0.07% Portfolio value: 2.53M Avg. open price: $3.17 Current price: $1.95 P/L: -38.42% Bought +2.63% shares Q2 2022	share	0.07%	2.53M	$3.17	$1.95	-38.42%	Bought +2.63% shares Q2 2022
Biotechnology Theseus Pharmaceuticals, Inc. Portfolio share: 0.07% Portfolio value: 2.53M Avg. open price: N/A Current price: $6.03 P/L: N/A N/A Q4 2021	share	0.07%	2.53M	N/A	$6.03	N/A	N/A Q4 2021
Biotechnology Icosavax, Inc. Portfolio share: 0.06% Portfolio value: 2.46M Avg. open price: $16.02 Current price: $3.19 P/L: -80.08% Bought +2.55% shares Q3 2022	share	0.06%	2.46M	$16.02	$3.19	-80.08%	Bought +2.55% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 2.46M Avg. open price: $86.79 Current price: $20.4 P/L: -76.49% Bought +57.14% shares Q3 2021	share	0.06%	2.46M	$86.79	$20.4	-76.49%	Bought +57.14% shares Q3 2021
Biotechnology Spruce Biosciences, Inc. Portfolio share: 0.06% Portfolio value: 2.22M Avg. open price: $13.79 Current price: $1.17 P/L: -91.52% Bought +0.31% shares Q4 2021	share	0.06%	2.22M	$13.79	$1.17	-91.52%	Bought +0.31% shares Q4 2021
Shell Companies Jiya Acquisition Corp. Portfolio share: 0.05% Portfolio value: 2.05M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.05%	2.05M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology IMARA Inc. Portfolio share: 0.05% Portfolio value: 1.92M Avg. open price: $5.77 Current price: $3.87 P/L: -32.95% Bought +0.01% shares Q1 2022	share	0.05%	1.92M	$5.77	$3.87	-32.95%	Bought +0.01% shares Q1 2022
Biotechnology Aeglea BioTherapeutics, Inc. Portfolio share: 0.05% Portfolio value: 1.79M Avg. open price: $3.51 Current price: $0.47 P/L: -86.60% Bought +11.13% shares Q3 2022	share	0.05%	1.79M	$3.51	$0.47	-86.60%	Bought +11.13% shares Q3 2022
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 1.54M Avg. open price: $13.18 Current price: $1.89 P/L: -85.66% Sold -22.22% shares Q2 2022	share	0.04%	1.54M	$13.18	$1.89	-85.66%	Sold -22.22% shares Q2 2022
Biotechnology Vincerx Pharma, Inc. Portfolio share: 0.04% Portfolio value: 1.53M Avg. open price: $1.89 Current price: $0.7 P/L: -62.95% Bought +36.16% shares Q3 2022	share	0.04%	1.53M	$1.89	$0.7	-62.95%	Bought +36.16% shares Q3 2022
Biotechnology Tempest Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 1.43M Avg. open price: $14.47 Current price: $1.65 P/L: -88.60% Bought +165.56% shares Q4 2021	share	0.04%	1.43M	$14.47	$1.65	-88.60%	Bought +165.56% shares Q4 2021
NEUROCRINE BIOSCIENCES INC Portfolio share: 0.04% Portfolio value: 1.41M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2018	share	0.04%	1.41M	N/A	N/A	N/A	N/A Q2 2018
Drug Manufacturers—Specialty & Generic AcelRx Pharmaceuticals, Inc. Portfolio share: 0.03% Portfolio value: 1.32M Avg. open price: $1.03 Current price: $2.19 P/L: +113.42% Bought +0.05% shares Q1 2022	share	0.03%	1.32M	$1.03	$2.19	+113.42%	Bought +0.05% shares Q1 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.03% Portfolio value: 1.05M Avg. open price: $35.22 Current price: $16.32 P/L: -53.66% N/A Q3 2022	share	0.03%	1.05M	$35.22	$16.32	-53.66%	N/A Q3 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.02% Portfolio value: 955K Avg. open price: $16.58 Current price: $3.47 P/L: -79.07% Bought +2.72% shares Q1 2022	share	0.02%	955K	$16.58	$3.47	-79.07%	Bought +2.72% shares Q1 2022
Biotechnology Compugen Ltd. Portfolio share: 0.02% Portfolio value: 848K Avg. open price: $6.65 Current price: $1.1 P/L: -83.45% Bought +0.48% shares Q4 2021	share	0.02%	848K	$6.65	$1.1	-83.45%	Bought +0.48% shares Q4 2021
Biotechnology Atreca, Inc. Portfolio share: 0.02% Portfolio value: 726K Avg. open price: $13.37 Current price: $1 P/L: -92.56% Bought +0.59% shares Q4 2021	share	0.02%	726K	$13.37	$1	-92.56%	Bought +0.59% shares Q4 2021
Biotechnology Applied Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 653K Avg. open price: $27.71 Current price: $0.9 P/L: -96.75% Bought +10.36% shares Q1 2021	share	0.02%	653K	$27.71	$0.9	-96.75%	Bought +10.36% shares Q1 2021
Biotechnology PhaseBio Pharmaceuticals, Inc. Portfolio share: 0.01% Portfolio value: 479K Avg. open price: $3.97 Current price: $0.07 P/L: -98.23% Sold -2.01% shares Q3 2022	share	0.01%	479K	$3.97	$0.07	-98.23%	Sold -2.01% shares Q3 2022
NEVRO CORP Portfolio share: 0.01% Portfolio value: 473K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2020	share	0.01%	473K	N/A	N/A	N/A	N/A Q2 2020
Biotechnology Altimmune, Inc. Portfolio share: 0.01% Portfolio value: 428K Avg. open price: N/A Current price: $11.09 P/L: N/A N/A Q3 2022	call	0.01%	428K	N/A	$11.09	N/A	N/A Q3 2022
NUVATION BIO INC Portfolio share: 0.00% Portfolio value: 27K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.00%	27K	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.09 Current price: $2.36 P/L: -86.19% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.09	$2.36	-86.19%	Sold -100.00% shares Q3 2022
RADIUS HEALTH INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $76.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$76.01	N/A	Sold -100.00% shares Q3 2022
THERAVANCE BIOPHARMA INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Sierra Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.39 Current price: $54.99 P/L: +216.17% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.39	$54.99	+216.17%	Sold -100.00% shares Q3 2022
Biotechnology Prelude Therapeutics Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $58.04 Current price: $6.2 P/L: -89.32% Sold -100.00% shares Q3 2022	share	0.00%	0	$58.04	$6.2	-89.32%	Sold -100.00% shares Q3 2022
Biotechnology Epizyme, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.38 Current price: $1.46 P/L: -80.21% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.38	$1.46	-80.21%	Sold -100.00% shares Q3 2022

Showing TOP 135 ROCK SPRINGS CAPITAL MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ROCK SPRINGS CAPITAL MANAGEMENT LP?

The biggest position of the ROCK SPRINGS CAPITAL MANAGEMENT LP is Humana Inc. (HUM) with 5.35% portfolio share worth of 206.93M US dollars.

Top 5 ROCK SPRINGS CAPITAL MANAGEMENT LP's holdings represent 20.97% of the portfolio:

Humana Inc. (HUM) – 5.35%
agilon health, inc. (AGL) – 4.69%
Immunocore Holdings plc (IMCR) – 4.24%
UnitedHealth Group Incorporated (UNH) – 3.52%
argenx SE (ARGX) – 3.19%

Who is the portfolio manager of ROCK SPRINGS CAPITAL MANAGEMENT LP?

The portfolio manager of the ROCK SPRINGS CAPITAL MANAGEMENT LP is .

What is the total asset value of the ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio?

ROCK SPRINGS CAPITAL MANAGEMENT LP total asset value (portfolio value) is 3.87B US dollars.

Who is ?

is the portfolio manager of the ROCK SPRINGS CAPITAL MANAGEMENT LP.

What is (ROCK SPRINGS CAPITAL MANAGEMENT LP) fund performance?

ROCK SPRINGS CAPITAL MANAGEMENT LP's quarterly performance is +8.56%, annualy -32.99%. In the past 3 years, the value of 's portfolio has decreased by -26%. In the past 5 years, the value of the portfolio has decreased by -27%.

What is the ROCK SPRINGS CAPITAL MANAGEMENT LP CIK?

ROCK SPRINGS CAPITAL MANAGEMENT LP's Central Index Key is 0001595725 .

ROCK SPRINGS CAPITAL MANAGEMENT LP Holdings

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

ROCK SPRINGS CAPITAL MANAGEMENT LP 1 year portfolio value change:

ROCK SPRINGS CAPITAL MANAGEMENT LP 3 years portfolio value change:

ROCK SPRINGS CAPITAL MANAGEMENT LP 5 years portfolio value change: